Optimal Timing of Surgery after Neoadjuvant Chemotherapy of Breast Cancer

Borna Farazmand (1), Maisa Yamrali (2), Reza Ghalehtaki (3), Mehran Habibi (4)
(1) Radiation Oncology Research Center (RORC), Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran,
(2) Radiation Oncology Research Center (RORC), Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran,
(3) Radiation Oncology Research Center (RORC), Department of Radiation Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran,
(4) Department of Surgery, Johns Hopkins Bayview Campus, Baltimore, USA

Résumé

NA

##article.full_articles##

##article.generated_from_xml##

Auteurs-es

Borna Farazmand
Maisa Yamrali
Reza Ghalehtaki
Mehran Habibi
mhabibi2@jhmi.edu (##journal.primary_contact##)
1.
Farazmand B, Yamrali M, Ghalehtaki R, Habibi M. Optimal Timing of Surgery after Neoadjuvant Chemotherapy of Breast Cancer. Arch Breast Cancer [Internet]. 6 mars 2017 [cité 12 janv. 2026];4(1):1-3. Disponible à: https://archbreastcancer.com/index.php/abc/article/view/121
Télécharger la référence
Endnote/Zotero/Mendeley (RIS)

##plugins.themes.novelty.article.details##

Articles les plus lus du,de la,des même-s auteur-e-s

Articles similaires

<< < 1 2 3 4 > >> 

Vous pouvez également Lancer une recherche avancée d’articles similaires à cet article.